GlassScriptPhysician profile
Jennifer E Caballero
NPI 1508142803
$7,101.31
in general payments reported to CMS, 2019-2025
33 companies · $2,344 in 2025
The $2,344 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,509 · 2022: $628 · 2023: $1,048 · 2024: $1,573 · 2025: $2,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,848 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,848.08 |
| Education | $116.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,110.46 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $728.72 | 2021-2025 | Ofev, Jascayd |
| Insmed, INC. | $668.91 | 2022-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $592.26 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $541.58 | 2021-2025 | Tyvaso, Orenitram, Remodulin |
| Actelion Pharmaceuticals US, INC. | $498.51 | 2021-2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $402.70 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Grifols USA, LLC | $382.95 | 2021-2025 | Prolastin-C Liquid, Xembify |
| Genzyme Corporation | $266.66 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $238.18 | 2021-2025 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $220.58 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $200.50 | 2023-2025 | Winrevair, Zerbaxa, Dificid |
| Inspire Medical Systems, INC. | $193.04 | 2023-2025 | Inspire |
| Electromed, INC. | $180.40 | 2021-2025 | Smartvest |
| Verona Pharma, INC. | $131.29 | 2025 | Ohtuvayre |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $127.50 | 2021-2023 | Xarelto |
| Shionogi INC | $79.04 | 2022-2024 | Fetroja |
| Philips North America LLC | $76.78 | 2021-2022 | |
| Inogen, INC. | $74.50 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ani Pharmaceuticals, INC. | $60.31 | 2025 | Purified Cortrophin Gel |
| Nabriva Therapeutics, Plc | $39.23 | 2021-2022 | |
| Mylan Specialty L.P. | $38.01 | 2021-2023 | Yupelri |
| Harmony Biosciences LLC | $31.93 | 2021 | |
| Baxter Healthcare | $31.34 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Paratek Pharmaceuticals, INC. | $27.41 | 2021-2022 | |
| Boston Scientific Corporation | $25.36 | 2024 | |
| Lilly USA, LLC | $21.91 | 2025 | Zepbound |
| Mallinckrodt Hospital Products INC. | $20.65 | 2023 | Terlivaz |
| Pharming Healthcare, INC. | $20.18 | 2023 | Ruconest |
| Genentech USA, INC. | $19.87 | 2022 | |
| Jazz Pharmaceuticals INC. | $18.06 | 2021 | |
| Covis Pharma Gmbh | $16.96 | 2022 | |
| Tactile Systems Technology INC | $15.53 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Caballero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.